Wake Forest Institute for Regenerative Medicine

Wake Forest Institute for Regenerative Medicine is a premier research center dedicated to developing clinical therapies that replace, repair, or regenerate damaged tissues and organs. Founded in 2004 and based at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, the institute operates as a key component of the larger Atrium Health Wake Forest Baptist academic medical system. Under the leadership of its founding director, Dr. Anthony Atala, it has become internationally recognized for pioneering work in bioprinting, organ fabrication, and translating laboratory discoveries into patient treatments.

History and founding

The institute was formally established in 2004, building upon foundational research in urology and tissue engineering conducted at Wake Forest University School of Medicine since the 1990s. Its creation was spearheaded by Dr. Anthony Atala, a pediatric urologist and researcher who had already gained prominence for engineering the first laboratory-grown organ, a bladder, implanted into a human patient. The founding vision was to consolidate multidisciplinary expertise to accelerate the field of regenerative medicine from basic science to clinical application. This initiative received significant support from the United States Armed Forces, particularly through collaborations with the United States Department of Defense aimed at treating battlefield injuries.

Research focus and programs

The institute's research portfolio is organized around several core programs targeting specific organ systems and technological platforms. Major research thrusts include the engineering of replacement tissues for the urinary tract, kidney, musculoskeletal system, and vascular system. A flagship program is the development of sophisticated bioprinting technologies to create complex, three-dimensional tissue structures. Other key programs focus on developing cell therapies and bioactive scaffolds, as well as pioneering work on decellularization and recellularization of donor organs to create transplantable grafts. Research spans from fundamental cell biology and biomaterials science to preclinical testing and clinical trials.

Key achievements and breakthroughs

The institute is renowned for several world-first achievements that have defined the field. In 2006, Dr. Anthony Atala and his team published the landmark report of the first successful implantation of laboratory-grown bladders into pediatric patients. Subsequent breakthroughs include the creation of the first bioprinted solid organ structures, such as miniature functional kidney prototypes, and the development of the Integrated Tissue and Organ Printing System. The institute's scientists also pioneered the use of a patient's own cells to engineer and implant vaginas for women with Mayer-Rokitansky-Küster-Hauser syndrome and have made significant advances in generating muscle, bone, and cartilage tissues for reconstruction.

Facilities and resources

The institute occupies state-of-the-art facilities within the Wake Forest Innovation Quarter in downtown Winston-Salem, North Carolina. Its laboratories are equipped for advanced cell culture, biomaterials fabrication, and 3D bioprinting, including custom-designed printer platforms. The complex houses specialized Good Manufacturing Practice facilities for translating research into compliant cell-based products for human use. These resources are part of the larger infrastructure of the Wake Forest University School of Medicine and the adjacent Atrium Health Wake Forest Baptist Medical Center, providing direct connections to clinical environments.

Leadership and organization

The institute has been led since its inception by Director Dr. Anthony Atala, who also serves as Chair of the Department of Urology at the medical school. The organizational structure integrates over 400 researchers, physicians, and staff across more than 20 different scientific and medical specialties, fostering a highly collaborative environment. Leadership includes associate directors overseeing specific research domains, such as vascular biology and translational research. The institute operates under the governance of Wake Forest University School of Medicine and is a central pillar of the regenerative medicine strategy for Atrium Health.

Collaborations and partnerships

The institute maintains an extensive network of strategic collaborations with academic, government, and industry partners globally. It has long-standing research partnerships with the United States Department of Defense, managed through the Armed Forces Institute of Regenerative Medicine consortium, focusing on treating combat-related injuries. Other key academic partners include the Massachusetts Institute of Technology, Harvard University, and the University of Pittsburgh. The institute also collaborates with numerous biotechnology and pharmaceutical companies to advance technology commercialization and engages in international initiatives with institutions like the Karolinska Institutet in Sweden.